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Background
Diabetes and obesity are well established risk factors for
the development of endometrial cancer. We hypothesized
that circulating cytokines associated with diabetes and
obesity exert direct effects on primary human endometrial
cell proliferation and transformation and worsen pathol-
ogy in endometrial cancer patients.
Methods
The effects of insulin and insulin like growth factors 1
and 2 (IGF1 and 2) on proliferation were measured in
primary cultures of human endometrial cells using a
cytotoxicity assay, while transformation was measured by
soft agar colony formation and histologic evaluation of
and organotypic model of endometrial carcinogenesis
and chemoprevetion [1]. Akt phosphorylation status was
measured by Western blot. Levels of leptin, adiponectin
adipsin, c-peptide, tumor necrosis factor a (TNFa)
chemokine (C-C motif) ligand 2 (CCL2, also called
monocyte chemotactic protein-1 or MCP-1), Interleukin
(IL)-1b, IL10, vascular endothelial growth factor (VEGF)
and insulin in serum from 84 endometrial cancer patients
were measured using multiplex magnetic bead assays
(BioRad and Millipore). Glucose was measured using a
kit (Cayman), and HOMA Scores were calculated. These
biomarkers were compared with tumor stage, grade,
recurrence of disease and age at diagnosis using Spear-
man Correlation.
Results
Insulin, IGF1 and IGF2 caused dose-responsive induction
of endometrial cell proliferation, which surprisingly was
associated with loss of Akt phosphorylation on Ser473.
Insulin treatment as a single agent induced anchorage-
independent colony formation in the soft agar assay and
histologic features of transformed cells in organotypic cul-
tures. Insulin also enhanced these transformation mea-
sures induced by 7,12-Dimethylbenz(a)anthracene
(DMBA) carcinogen. Elevated CCL2 in serum of endome-
trial cancer patients was significantly associated with
worse stage of disease (r=0.262, p=0.018). Reduced serum
TNFa was significantly associated with increased age at
diagnosis (r=0.332, p=0.048). No other associations
between biomarkers and patient characteristics were
noted.
Conclusions/discussion
Insulin, IGF1 and IGF2 have direct effects on normal
endometrial cell proliferation and transformation potential
implicating these cytokines in the increased risk of endo-
metrial cancer associated with diabetes and obesity. The
decreased TNFa found to be associated with increased age
at diagnosis may be due to the known inverse association
of TNFa with age and insulin levels. The association of
elevated CCL2 with tumor stage suggests that direct
effects of CCL2 on tumor and surrounding stromal cells
over-rides CCL2 recruitment of T-lymphocytes into
tumors to enhance tumor-specific immunity. Follow-up
studies are planned to validate the biomarker results in an
independent set of specimens and to evaluate the role of
Akt signaling in insulin and CCL2 effects on endometrial
carcinogenesis and progression.
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